Fellowship · Sacramento, CA
Sponsored by University of California Davis Health
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 424 citations · Hisham Hussan
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 179 citations · Karen Matsukuma
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Hepatology (Baltimore, Md.) · 2023 · 350 citations · Christopher Bowlus
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
The New England journal of medicine · 2024 · 257 citations · Christopher Bowlus
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
The New England journal of medicine · 2024 · 236 citations · Christopher Bowlus
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 239 citations · Hisham Hussan
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH).
Nature reviews. Drug discovery · 2025 · 135 citations · Albert Do
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
Journal of hepatology · 2021 · 397 citations · Maria-Andreea Catana